YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Vytorin
Feds, State AGs Investigating Vytorin Marketing
Nov 4, 2008 | Parker Waichman Alonso LLP
Vytorin, Merck and Schering-Plough's controversial cholesterol medication, is the subject of two more state and federal investigations. In a...
New Haven to Sue Merck and Schering-Plough
Oct 16, 2008 | Parker Waichman Alonso LLP
The city of New Haven, Connecticut, is reporting that over $400,000 in tax dollars were spent on Vytorin and Zetia for employees. Now,...
Vytorin Sales Dip Means Layoffs at Schering-Plough
Sep 23, 2008 | Parker Waichman Alonso LLP
The Vytorin controversy is still hurting sales of the once-blockbuster cholesterol drug, with prescriptions down one-third this year. To stem...
Vytorin Researcher Denies Cancer Link
Sep 19, 2008 | Parker Waichman Alonso LLP
A prominent statistician is continuing to insist that there is no link between Vytorin and cancer. In a blunt letter to a Congressional...
Vytorin Confusion Leaves Patients Wondering
Sep 8, 2008 | Parker Waichman Alonso LLP
Many patients - and probably some doctors - are scratching their heads over Vytorin. Though it has been on the market for four years, little is...
More Vytorin Questions from Congress
Sep 5, 2008 | Parker Waichman Alonso LLP
A Vytorin probe in Congress is expanding in scope. The House Energy and Commerce Committee has been investigating the safety and effectiveness...
Vytorin Study Release Criticized
Sep 3, 2008 | Parker Waichman Alonso LLP
The behavior of Vytorin makers, Merck and Schering-Plough, in releasing the results of an important clinical trial that indicated the cholesterol...
Vytorin Cancer Controversy Far from Over
Aug 28, 2008 | Parker Waichman Alonso LLP
News earlier this summer that Vytorin had been tied to a higher risk of cancer by a newly published study quickly faded from the...
Lawmakers Pressing for Answers on Vytorin Study
Aug 21, 2008 | Parker Waichman Alonso LLP
Two lawmakers want to know why the press release detailing a Vytorin study issued by drug makers Merck and Schering-Plough differed from information...
FDA Taking a Look at Vytorin - Cancer Link
Aug 21, 2008 | Parker Waichman Alonso LLP
Vytorin is being investigated by federal regulators for a possible link to cancer. The investigation stems from the publication last...
Vytorin
